Pricing Log in Create free account

Celyad SA (CYAD) vs Estrella Immunopharma, Inc. (ESLA)

Celyad SA and Estrella Immunopharma, Inc. are both Biotechnology companies. Celyad SA and Estrella Immunopharma, Inc. are of similar size ($23.8M and $23.3M). Across the 7 metrics below, Celyad SA leads on 4 and Estrella Immunopharma, Inc. on 3.

Valuation

Metric CYAD ESLA Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 11.18 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA — n/m 0.64
EV/Sales — n/m 9.21
Earnings yield (708.87%) (56.72%) (33.15%)
Free cash flow yield (438.06%) (50.75%) (25.50%)

Profitability

Metric CYAD ESLA Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin — 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% 148.05% (56.36%)
Return on assets 0.00% (416.74%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CYAD ESLA Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 113.33% (188.78%) 30.26%
Revenue growth, 5-year CAGR (63.51%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CYAD ESLA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.94 0.20 4.72
Net debt to EBITDA (1.62) 0.11 0.96

Dividend

Metric CYAD ESLA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CYAD ESLA Biotechnology median
Market cap 23.79m 23.28m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack